S S Legha, F M Muggia. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Alkylating Agents/therapeutic useAntineoplastic Agents/therapeutic useCyclophosphamide/therapeutic useDactinomycin/therapeutic useDoxorubicin/therapeutic useDrug Therapy, CombinationFluorouracil/therapeutic useGold Colloid, Radioactive/therapeutic useHumansMesothelioma/drug therapyMesothelioma/radiotherapyMesothelioma/surgeryMethotrexate/therapeutic useNitrogen Mustard Compounds/therapeutic usePalliative CarePeritoneal Neoplasms/drug therapyPeritoneal Neoplasms/radiotherapyPeritoneal Neoplasms/surgeryPhosphorus Radioisotopes/therapeutic usePleural Neoplasms/drug therapyPleural Neoplasms/radiotherapyPleural Neoplasms/surgeryRadiotherapy DosageThiotepa/therapeutic use
Substances: See more » Alkylating AgentsAntineoplastic AgentsGold Colloid, RadioactiveNitrogen Mustard CompoundsPhosphorus RadioisotopesDactinomycinDoxorubicinCyclophosphamideThiotepaFluorouracilMethotrexate
Year: 1977 PMID: 66990 DOI: 10.1016/s0305-7372(77)80016-9
Source DB: PubMed Journal: Cancer Treat Rev ISSN: 0305-7372 Impact factor: 12.111